L712-0354 Screening compound: N-(2-methylphenyl)-4-{2-[2-(4-methylphenyl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide

L712-0354 Screening compound: N-(2-methylphenyl)-4-{2-[2-(4-methylphenyl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide
L712-0354 Screening compound: N-(2-methylphenyl)-4-{2-[2-(4-methylphenyl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L712-0354
N-(2-methylphenyl)-4-{2-[2-(4-methylphenyl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L712-0354

Molecular Formula

C27H30N6O (C27 H30 N6 O)

Compound Name

N-(2-methylphenyl)-4-{2-[2-(4-methylphenyl)-3H-imidazo[4,5-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide

IUPAC name

N-(2-methylphenyl)-4-{2-[2-(4-methylphenyl)-3H-imidazo[45-b]pyridin-3-yl]ethyl}piperazine-1-carboxamide

SMILES

Cc(cc1)ccc1-c1nc2cccnc2n1CCN(CC1)CCN1C(Nc1c(C)cccc1)=O

InChI

InChI=1S/C27H30N6O/c1-20-9-11-22(12-10-20)25-29-24-8-5-13-28-26(24)33(25)19-16-31-14-17-32(18-15-31)27(34)30-23-7-4-3-6-21(23)2/h3-13H,14-19H2,1-2H3,(H,30,34)

InChI Key

GEFWOVHHQYFDGI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15133594

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

454.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.358

Distribution Coefficient, logD

4.353

Water Solubility, LogSw

-4.07

Polar Surface Area

48.342

Acid Dissociation Constant (pKa)

13.79

Base Dissociation Constant (pKb)

5.48

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

29.60

L712-0354 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

CNS Targets (44014 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

PI3K-Targeted Library (17255 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with L712-0354 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L712-0354?
Check Price and Availability of L712-0354, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L712-0354 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L712-0354
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L712-0354
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L712-0354 available by request